Problems
What will AGI do for Rare Disease Referral Pipeline?
Primary care physicians routinely miss the early clinical signatures of rare diseases, trapping patients in multi-year diagnostic odysseys. Operating under strict time constraints, these providers evaluate isolated symptoms without the bandwidth to correlate them against thousands of known rare conditions. Consequently, life science companies and specialized medical centers fail to locate appropriate patients for targeted therapies and clinical trials.